secwatch.observer — SEC 8-K summary
======================================

Issuer:     agilon health, inc. (AGL)
CIK:        0001831097
Form:       8-K
Filed at:   2026-03-18T23:59:59+00:00
Accession:  0001628280-26-019406
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

agilon health to effect 1-for-25 reverse stock split on March 30, 2026 to maintain NYSE listing
--------------------------------------------------------------------------------

- Stockholders approved reverse split at special meeting on March 17; votes were 356,574,789 for, 6,187,388 against, 365,864 abstained.
- Board set ratio at 1-for-25; effective 5:01 p.m. ET March 30; split-adjusted trading begins March 31 under ticker AGL.
- Approximately 16,605,993 shares outstanding post-split; no fractional shares issued, cash in lieu paid.
- Reverse split intended to bring bid price above $1.00 to comply with NYSE continued listing requirements.
- CUSIP for new shares: 00857U 206; transfer agent Computershare will handle exchange.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831097/000162828026019406/0001628280-26-019406-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831097/000162828026019406/agl-20260317.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-019406

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer